State Street’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$755M Sell
14,861,409
-1,504,069
-9% -$70.2M 0.03% 463
2025
Q4
$483M Sell
16,365,478
-743,117
-4% -$20.2M 0.02% 570
2025
Q3
$442M Sell
17,108,595
-162,036
-0.9% -$4.52M 0.02% 599
2025
Q2
$476M Sell
17,270,631
-507,927
-3% -$13.4M 0.02% 562
2025
Q1
$504M Buy
17,778,558
+201,322
+1% +$7.14M 0.02% 531
2024
Q4
$731M Buy
17,577,236
+730,024
+4% +$34.9M 0.03% 458
2024
Q3
$1.13B Buy
16,847,212
+1,823,276
+12% +$167M 0.05% 342
2024
Q2
$1.78B Buy
15,023,936
+571,901
+4% +$72.4M 0.08% 226
2024
Q1
$1.54B Sell
14,452,035
-171,688
-1% -$17.3M 0.07% 259
2023
Q4
$1.45B Buy
14,623,723
+672,447
+5% +$56.6M 0.07% 260
2023
Q3
$1.44B Sell
13,951,276
-275,951
-2% -$30.8M 0.08% 240
2023
Q2
$1.73B Buy
14,227,227
+150,872
+1% +$20.1M 0.09% 212
2023
Q1
$2.16B Sell
14,076,355
-224,062
-2% -$37M 0.12% 156
2022
Q4
$2.57B Sell
14,300,417
-205,649
-1% -$33.6M 0.15% 142
2022
Q3
$1.72B Sell
14,506,066
-260,514
-2% -$39.5M 0.11% 179
2022
Q2
$2.11B Sell
14,766,580
-80,550
-0.5% -$11.5M 0.13% 160
2022
Q1
$2.56B Sell
14,847,130
-16,240
-0.1% -$2.73M 0.13% 156
2021
Q4
$3.77B Buy
14,863,370
+905,789
+6% +$265M 0.18% 106
2021
Q3
$5.37B Buy
13,957,581
+6,632,005
+91% +$2.45B 0.28% 69
2021
Q2
$1.72B Buy
7,325,576
+1,316,702
+22% +$235M 0.09% 210
2021
Q1
$787M Sell
6,008,874
-15,813
-0.3% -$2.29M 0.05% 377
2020
Q4
$629M Sell
6,024,687
-559,240
-8% -$56.6M 0.04% 419
2020
Q3
$466M Buy
6,583,927
+556,953
+9% +$38.8M 0.03% 447
2020
Q2
$387M Buy
6,026,974
+530,003
+10% +$29M 0.03% 492
2020
Q1
$165M Buy
5,496,971
+87,157
+2% +$2.01M 0.01% 675
2019
Q4
$106M Buy
5,409,814
+3,258,554
+151% +$57.8M 0.01% 1011
2019
Q3
$34.2M Buy
2,151,260
+1,841,385
+594% +$27.2M ﹤0.01% 1703
2019
Q2
$4.54M Buy
309,875
+7,895
+3% +$170K ﹤0.01% 2881
2019
Q1
$6.14M Buy
+301,980
New +$5.6M ﹤0.01% 2658

Other funds holding MRNA